• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Park-Ohio Industries Inc.

  • ID: 1752464
  • October 2008
  • Standard & Poors


  • Park-Ohio Industries Inc.
  • MORE

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Significant positions in diverse specialty markets; and Some product, end-market, and customer diversity. Exposure to cyclical, competitive markets; Highly leveraged; and Weak cash flow generation. The ratings on Park-Ohio Industries Inc. reflect the company's highly leveraged financial profile, which more than offsets its business profile as a diversified operator of logistics and manufacturing businesses, serving cyclical and competitive end markets. Cleveland, Ohio-based Park-Ohio, a wholly owned subsidiary of unrated Park-Ohio Holdings Corp., operates three business segments, which serve a variety of end markets, including transportation, semiconductors, industrial equipment, agricultural equipment, construction equipment, and aerospace. The supply technologies segment (formerly known as integrated logistics service), which generated around 48% of sales in the first six months of 2008, supplies production components...

Companies mentioned in this report are: Park-Ohio Industries Inc.
Action: Review

Note: Product cover images may vary from those shown

Park-Ohio Industries Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.